By Scientia Professor Vlado Perkovic

Conference Papers

Mann JFE; Tuttle KR; Pratley RE; Mahaffey KW; Arici M; Belmar N; Bonefeld K; Chernin G; Correa-Rotter R; Gillard P; Hadjadj S; Idorn T; Ji L; Linder M; Schmieder RE; Shamkhalova M; Sriwijitkamol A; Perkovic V; Rossing P, 2025, 'Impact of Semaglutide on Kidney, Cardiovascular, and Mortality Outcomes by Baseline BMI and Weight Loss in People with T2D and CKD-Data from the FLOW Trial', in DIABETES, AMER DIABETES ASSOC, IL, Chicago, presented at 85th Scientific Sessions of the American-Diabetes-Association (ADA), IL, Chicago, 20 June 2025 - 23 June 2025, http://dx.doi.org/10.2337/db25-1971-LB

Perkovic V; Barratt J; Carroll K; Fajardo C; Hafkin J; Lafayette R; Liew A; Shah L; Suzuki Y; Tesar V; Trimarchi H; Wong MG; Xia J; Zhan H; Rizk D, 2025, 'PATIENT BASELINE CHARACTERISTICS IN THE ONGOING PHASE 3 VISIONARY TRIAL: A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF SIBEPRENLIMAB FOR IMMUNOGLOBULIN A NEPHROPATHY', in AMERICAN JOURNAL OF KIDNEY DISEASES, W B SAUNDERS CO-ELSEVIER INC

Tuttle K; Bakris G; Bang C; Bax W; Belmar N; Brown P; Cherney D; Chernin G; Lim SK; Mann J; Perkovic V; Pratley R; Ridker P; Rossing P; Schmieder R; Shamkhalova MS; Sreenivasamurthy L; Mahaffey K, 2024, 'Benefits of Semaglutide on Chronic Kidney Disease Outcomes by Cardiovascular Status or Risk in the FLOW trial', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, pp. E746 - E746, presented at American-Heart-Association Resuscitation Science Symposium, IL, Chicago, 16 November 2024 - 18 November 2024

Rossing P; Bakris GL; Perkovic V; Pratley R; Tuttle K; Mahaffey K; Idorn T; Nazal NB; Bosch-Traberg H; Rasmussen S; Busch RS; Schmieder R; Gillard P; Mann J, 2024, 'Kidney, cardiovascular and all-cause mortality outcomes of semaglutide with and without baseline MRA use in type 2 diabetes and CKD: a FLOW trial analysis', in DIABETOLOGIA, SPRINGER, SPAIN, Madrid, pp. S519 - S519, presented at 60th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SPAIN, Madrid, 09 September 2024 - 13 September 2024

Perkovic V; Barratt J; Radhakrishnan J; Rizk D; Trimarchi H; Khawaja Z; Leiske J; Sorensen B; King A; Jones-Burton C; Campbell K, 2023, 'A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BION-1301 IN ADULTS WITH IGA NEPHROPATHY', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ITALY, Milan, pp. I398 - I399, presented at 60th ERA Congress, ITALY, Milan, 15 June 2023 - 18 June 2023

Singh AK; Claggett BL; Perkovic V; Hiemstra T; Khavandi K; Lukas MA; Ranganathan P; Shannon JB; van Adelsberg J; Solomon S, 2023, 'HEART FAILURE IN ASCEND-ND AND ASCEND-D', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ITALY, Milan, pp. I453 - I455, presented at 60th ERA Congress, ITALY, Milan, 15 June 2023 - 18 June 2023

Heerspink HJ; Agarwal R; Bakris GL; Cherney D; Lam CSP; Neuen BL; Tuttle KR; Wanner C; Brinker MD; Dizayee S; Kolkhof P; Schloemer P; Vesterinen PH; Perkovic V, 2023, 'Design and Baseline Characteristics of the FIND-CKD Trial: Efficacy of Finerenone on Kidney Disease Progression in People with Non-Diabetic CKD', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 678 - 678

Tangri N; Ferguson T; Bamforth RJ; Arnott CG; Mahaffey K; Heerspink HJ; Perkovic V; Neuen BL, 2023, 'External Validation of a Machine Learning Model for Progression of CKD in the CREDENCE and CANVAS Trials', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 418 - 419

Ha JT; Hiremath S; Jun M; Palmer SC; Wheeler DC; Coyne DW; Perkovic V; Badve SV, 2023, 'LONG-TERM SAFETY OF HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE INHIBITORS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in NEPHROLOGY, WILEY, pp. 12 - 12

Ha J; Hiremath S; Jun M; Palmer S; Wheeler DC; Coyne DW; Perkovic V; Badve S, 2023, 'Long-Term Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors in CKD: A Systematic Review and Meta-Analysis of Randomized Trials', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 367 - 367

Jun M; Wick J; Neuen BL; Kotwal SS; Badve S; Chalmers JP; Jardine M; Perkovic V; Gallagher MP; Ronksley PE, 2023, 'The Prevalence of CKD in Australian Primary Care: Analysis of a National General Practice Dataset', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 373 - 373

Sharma AA; Neuen BL; Fletcher RA; Slee A; Rapattoni W; Ang FG; Arnott C; Levin A; Verma S; Perkovic V; Mahaffey KW, 2023, 'Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: insights from the CANVAS Program and CREDENCE trial', in EUROPEAN JOURNAL OF HEART FAILURE, WILEY, pp. 177 - 178

Kolkailah AA; Marx N; Rosenstock J; Johansen OE; Cooper ME; Alexander JH; Toto R; Wanner C; Espeland MA; Mattheus M; Schnaidt S; Perkovic V; Gollop ND; McGuire DK, 2022, 'Assessment Of Associations Between Hypoglycemia And Cardiovascular Outcomes In The Randomized CARMELINA And CAROLINA Trials Of The Antihyperglycemic Medication Linagliptin', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, presented at Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, IL, Chicago, 05 November 2022 - 06 November 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000890856904142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Koshino A; Schechter M; Sen T; Neuen BL; Arnott C; Neal B; Perkovic V; Ridker PM; Tuttle KR; Hansen MK; Heerspink HJL, 2022, 'Interleukin-6 and cardiovascular outcome in patients with type 2 diabetes: new insights from CANVAS', in DIABETOLOGIA, SPRINGER, SWEDEN, Stockholm, pp. S282 - S282, presented at 58th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SWEDEN, Stockholm, 19 September 2022 - 23 September 2022

Perkovic V; Baeres F; Bakris G; Bosch-Traberg H; Idorn T; Mahaffey K; Mann J; Mersebach H; Rossing P; Tuttle K; Pratley R, 2022, 'BASELINE CHARACTERISTICS OF THE FLOW TRIAL POPULATION: KIDNEY OUTCOMES TRIAL WITH ONCE-WEEKLY SEMAGLUTIDE IN PEOPLE WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, FRANCE, Paris, pp. I893 - I894, presented at 59th Congress of the European-Renal-Association (ERA), FRANCE, Paris, 19 May 2022 - 22 May 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000813350704181&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Perkovic V; Tuttle KR; Pergola PE; Mahaffey KW; Patel UD; Ishida JH; Chen F; Crans G; Kustra R; Trivedi M; Heerspink HJL; Rossing P; Kashihara N; Chertow G, 2022, 'A Phase 2b Randomized Controlled Trial of Selonsertib in Moderate to Severe Diabetic Kidney Disease (MOSAIC)', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 28 - 28

Rizk D; Perkovic V; Lafayette RA; Trimarchi H; Barratt J; Carroll K; Tesar V; Zhang H; Suzuki Y; Liew A; Wong MG; Leslie BR; Mathur M; Hafkin J, 2022, 'A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Patients With IgA Nephropathy', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 799 - 799

Mahaffey KW; Baeres FMM; Bakris G; Bosch-Traberg H; Gislum M; Lawson J; Mann JFE; Mersebach H; Perkovic V; Rossing P; Tuttle K; Pratley R, 2022, 'Baseline cardiovascular risk in subjects with type 2 diabetes and chronic kidney disease from the FLOW trial', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 2617 - 2617

Singh AK; Acharya A; Carroll K; Lopes RD; McCausland FR; Mulloy L; Perkovic V; Solomon S; Waikar SS; Wanner C; Wong MG; Cobitz AR; Mallett SA; Shaddinger BC; McMurray JJV, 2022, 'Causes of death in patients with chronic kidney disease: insights from the ASCEND-D and ASCEND-ND cardiovascular outcomes trials', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 1053 - 1053

McCausland F; Singh A; Claggett B; Carroll K; Wittes J; McMurray JJV; Perkovic V; Snappin S; Lopes R; Solomon S, 2022, 'Differing approaches to analyse on-treatment cardiovascular events comparing daprodustat with darbepoetin: results from the ASCEND-ND trial', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 2621 - 2621

Koshino A; Oshima M; Arnott CG; Fletcher RA; Perkovic V; Heerspink HJL; Neuen BL, 2022, 'Effect of Canagliflozin on Markers of Hepatic Steatosis and Fibrosis in Patients With Type 2 Diabetes and CKD', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 673 - 674

Rovin BH; Barratt J; Zhang H; Rizk D; Kashihara N; Maes BD; Trimarchi H; Sprangers B; Meier M; Kollins D; Magirr AR; Junge G; Perkovic V, 2022, 'Effect of Iptacopan on Proteinuria and Complement Biomarkers Over Time in IgA Nephropathy', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 33 - 34

Smeijer JD; Koomen J; Kohan DE; McMurray J; Bakris GL; Correa-Rotter R; Hou FF; Kitzman D; Makino H; Perkovic V; Rossing P; de Zeeuw D; Heerspink HJL, 2022, 'Gene Polymorphism in Organic Anion Transporters Determine the Long-Term Efficacy and Safety of Atrasentan in Patients With Type 2 Diabetes and CKD', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 116 - 116

Ha J; Freedman B; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve S, 2022, 'Lower Glomerular Filtration Rate and Higher Albuminuria Are Associated With Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 297 - 298

Singh AK; McCausland FR; Claggett B; Wanner C; Wiecek A; Atkins MB; Carroll K; Perkovic V; McMurray J; Wittes J; Snapinn SM; Blackorby A; Barker T; Dimino TL; Mallett S; Meadowcroft AM; Cobitz AR; Solomon SD, 2022, 'On-Treatment Cancer Safety Events With Daprodustat vs. Erythropoiesis-Stimulating Agents: Post Hoc Analyses of ASCEND-ND and ASCEND-D', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 631 - 631

Neuen BL; Oshima M; Perkovic V; Arnott C; Bakris G; Cannon CP; Charytan DM; Jardine M; Levin A; Neal B; Pollock C; Wheeler DC; Mahaffey KW; Heerspink HJL, 2021, 'Effects of canagliflozin on hyperkalaemia and serum potassium in people with diabetes and chronic kidney disease: insights from the CREDENCE trial', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, pp. 2647 - 2647, http://dx.doi.org/10.26190/unsworks/28409

Tiku A; Boudville N; Brown F; Cass A; Clarke P; Day R; de Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones G; Kanellis J; Pascoe E; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker R; Walters G; Johnson D; Badve S; Dalbeth N, 2021, 'Urate-lowering Therapy for Prevention of Gout: Prespecified Analyses from the CKD-FIX Trial', in ARTHRITIS & RHEUMATOLOGY, WILEY, pp. 1372 - 1373, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000744545202187&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Perkovic V; Blackorby A; Cizman B; Carroll K; Cobitz A; Davies R; DiMino T; Jha V; Johansen K; Lopes R; Kler L; Macdougall I; McMurray J; Meadowcroft A; Obrador G; Solomon S; Taft L; Wanner C; Waikar SS; Wheeler D; Wiecek AJ; Singh A, 2021, 'ASCEND-ND: STUDY DESIGN AND BASELINE CHARACTERISTICS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, presented at 58th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA), ELECTR NETWORK, 05 June 2021 - 08 June 2021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713465600213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tuttle KR; Brosius FC; Cavender MA; Fioretto P; Fowler KJ; Heerspink HJL; Manley T; McGuire DK; Molitch ME; Mottl AK; Perreault L; Rosas SE; Rossing P; Sola L; Vallon V; Wanner C; Perkovic V, 2021, 'Sglt2 inhibition for ckd and cardiovascular disease in type 2 diabetes: Report of a scientific workshop sponsored by the national kidney foundation', in Diabetes, pp. 1 - 16, http://dx.doi.org/10.2337/dbi20-0040

Singh AK; Carroll K; Perkovic V; Solomon SD; Jha V; Johansen KL; Lopes RD; Macdougall IC; Obrador GT; Waikar SS; Wanner C; Wheeler DC; Wiecek A; Blackorby A; Cizman B; Cobitz AR; Davies R; Dimino TL; Dole JF; Kler L; Meadowcroft AM; Taft L; Zhu X; McMurray J, 2021, 'ASCEND Program: Efficacy and Safety from ASCEND-D and -ND and Overall MACE Finding', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. B2 - B3

Darshi M; Tefera E; Gao B; Weidner-Wells M; Reilly DF; Coorey C; Tang O; Yang J; Neal B; Arnott CG; Mahaffey KW; Perkovic V; Hansen MK; Ferrannini E; Figtree G, 2021, 'Circulating Metabolites to Predict Renal Outcomes in CANVAS Type 2 Diabetes Mellitus Population', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 47 - 47

Levin A; Cherney D; Wheeler DC; Gogate J; Haynes M; Perkovic V, 2021, 'Effects of Canagliflozin (CANA) on Kidney Outcomes: Pooled Analyses from the CANVAS Program and CREDENCE', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 263 - 264

Pergola PE; Davidson M; Devalaraja M; Ivkovic M; Johansen NJ; Raj DS; Sode BF; Tuttle KR; Perkovic V, 2021, 'IL-6 Inhibitor Ziltivekimab Increases Serum Hemoglobin and Iron Biomarkers in Patients with CKD Stage 3-5: A RESCUE Trial Analysis', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 190 - 190

Waijer SW; Gansevoort RT; Bakris GL; Correa-Rotter R; Hou FF; Kohan DE; Makino H; McMurray J; Perkovic V; Tobe SW; Parving H-H; de Zeeuw D; Heerspink HJL, 2021, 'The Effect of Atrasentan on Kidney and Heart Failure Outcomes by Baseline Albuminuria and Kidney Function: A Post Hoc Analysis of the SONAR Trial', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. 728 - 728

Perkovic V; Lv J; Wong MG; Hladunewich MA; Jha V; Monaghan H; Zhang H, 2021, 'The TESTING Study: Steroids vs. Placebo in High Risk IgA Nephropathy', in JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, AMER SOC NEPHROLOGY, pp. B1 - B1

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; De Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'THE EFFECTS OF ALLOPURINOL ON THE PROGRESSION OF CHRONIC KIDNEY DISEASE ACCORDING TO BASELINE KIDNEY FUNCTION: PRE-SPECIFIED ANALYSES OF THE CKD-FIX TRIAL', in NEPHROLOGY, WILEY, pp. 60 - 60, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200189&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mann JFE; Buse JB; Idorn T; Leiter LA; Pratley R; Rasmussen S; Vilsboll T; Wolthers B; Perkovic V, 2020, 'Renoprotection with semaglutide and liraglutide: Direct or indirect effects?', in DIABETOLOGIA, SPRINGER, ELECTR NETWORK, pp. S67 - S68, presented at 56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), ELECTR NETWORK, 21 September 2020 - 25 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000565776600135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

O'Lone E; Viecelli AK; Craig JC; Tong A; Sautenet B; Herrington WG; Herzog CA; Jafar TH; Jardine M; Krane V; Levin A; Malyszko J; Rocco MV; Strippoli G; Tonelli M; Wang AYM; Wanner C; Zannad F; Winkelmayer WC; Wheeler DC; Manns B; Pecoits-Filho R; Harris T; Kleinpeter M; Ju A; Cho Y; Gutman T; Bernier-Jean A; James L; Hamiwka L; Jardine A; Bello A; Stengel B; Schiller B; Johnson D; Bavlovlenkov E; Caskey F; Gillespie B; Block G; Phan HA; Heerspink HL; Madero M; Ruospo M; Unruh M; Laville M; Bansal N; Mark P; Blankestijn PJ; Roy-Chaudhury P; Perlman R; Agarwal R; Mehrotra R; Seliger S; Shafi T; Hiemstra T; Jassal V; Perkovic V; Simplice A; White D; Eilers D; Alexander H; Landry Y; Landry G; Wilkie C, 2020, 'Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop', in American Journal of Kidney Diseases, pp. 109 - 120, http://dx.doi.org/10.1053/j.ajkd.2020.01.022

Tuttle K; Cherney D; Hadjadj S; Idorn T; Mosenzon O; Perkovic V; Rasmussen S; Wolthers B; Bain SC, 2020, 'EFFECTS OF SEMAGLUTIDE ON CHRONIC KIDNEY DISEASE OUTCOMES: A POST HOC POOLED ANALYSIS FROM THE SUSTAIN 6 AND PIONEER 6 TRIALS', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, pp. 152 - 152, presented at 57th ERA-EDTA Congress, ELECTR NETWORK, 06 June 2020 - 09 June 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000562392100510&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tuttle K; Cherney D; Hadjadj S; Idorn T; Mosenzon O; Perkovic V; Rasmussen S; Wolthers B; Bain SC, 2020, 'REDUCTION IN THE RATE OF EGFR DECLINE WITH SEMAGLUTIDE VS PLACEBO: A POST HOC POOLED ANALYSIS OF SUSTAIN 6 AND PIONEER 6', in NEPHROLOGY DIALYSIS TRANSPLANTATION, OXFORD UNIV PRESS, ELECTR NETWORK, pp. 183 - 183, presented at 57th ERA-EDTA Congress, ELECTR NETWORK, 06 June 2020 - 09 June 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000562392102160&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Levey AS; Gansevoort RT; Coresh J; Inker LA; Heerspink HL; Grams ME; Greene T; Tighiouart H; Matsushita K; Ballew SH; Sang Y; Vonesh E; Ying J; Manley T; de Zeeuw D; Eckardt KU; Levin A; Perkovic V; Zhang L; Willis K, 2020, 'Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency', in American Journal of Kidney Diseases, pp. 84 - 104, http://dx.doi.org/10.1053/j.ajkd.2019.06.009

Rosenstock J; Kahn SE; Johansen OE; Cooper ME; Marx N; Alexander JH; Toto R; Wanner C; Pfarr E; Schnaidt S; George JT; von Eynatten M; McGuire DK; Perkovic V; Zinman B, 2019, 'Interrelationship between hypoglycemia and CV and mortality outcomes in type 2 diabetes in the CARMELINA Trial', in DIABETES-METABOLISM RESEARCH AND REVIEWS, WILEY, PEOPLES R CHINA, Xiamen, presented at 23rd Scientific Meeting of the Chinese-Diabetes-Society, PEOPLES R CHINA, Xiamen, 20 November 2019 - 23 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000496157200137&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cannon CP; Perkovic V; Agarwal R; Baldassarre J; Bakris GL; Brenner BM; Charytan D; de Zeeuw D; Edwards R; Greene T; Heerspink HJL; Jardine M; Levin A; Li J-W; Neal B; Pollock C; Wheeler D; Zhang H; Zinman B; Mahaffey KW, 2019, 'Canagliflozin Reduces Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Chronic Kidney Disease Regardless of Baseline HbA1c, Including Those With HbA1c < 7%: Results From the CREDENCE Trial', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, PA, Philadelphia, presented at Scientific Sessions of the American-Heart-Association, PA, Philadelphia, 16 November 2019 - 18 November 2019, http://dx.doi.org/10.26190/unsworks/27739

Marx N; McGuire DK; Johansen O; Rosenstock J; Kahn SE; Cooper ME; Toto R; Wanner C; Pfarr E; Schnaidt SY; George JT; Von Eynatten M; Perkovic V; Zinman B; Alexander JA, 2019, 'First plus recurrent CV and hospitalization events in the CArdiovascular and Renal Microvascular outcomE study with LINAgliptin (CARMELINA) in patients with type 2 diabetes and cardiorenal disease', in EUROPEAN HEART JOURNAL, OXFORD UNIV PRESS, FRANCE, Paris, pp. 3877 - 3877, presented at Congress of the European-Society-of-Cardiology (ESC) / World Congress of Cardiology, FRANCE, Paris, 31 August 2019 - 04 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000507313003522&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McGuire DKK; Alexander JH; Perkovic V; Rosenstock J; Cooper ME; Wanner C; Toto R; Kahn SE; Zinman B; Woerle HJ; Baanstra D; Pfarr E; Schnaidt SY; Meinicke T; von Eynatten M; George JT; Johansen OE; Marx N, 2018, 'Effects of the DPP-4 Inhibitor Linagliptin on Heart Failure Outcomes in Patients With Type 2 Diabetes and Cardio-Renal Disease in CARMELINA', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, IL, Chicago, pp. E771 - E772, presented at Scientific Sessions of the American-Heart-Association (AHA) / Resuscitation Science Symposium, IL, Chicago, 09 November 2018 - 12 November 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000453713500040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Perkovic V; Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Desai M; Li Q; Deng H; Rosenthal N; Jardine M; Bakris G, 2018, 'Canagliflozin and cardiovascular outcomes in patients with chronic kidney disease', in DIABETOLOGIA, SPRINGER, GERMANY, Berlin, pp. S39 - S39, presented at 54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), GERMANY, Berlin, 01 October 2018 - 05 October 2018, http://dx.doi.org/10.26190/unsworks/28688

Ohkuma T; Jun M; Esq MW; Chalmers J; Perkovic V; Rodgers A, 2018, 'Acute Increase in Creatinine after Starting ACE Inhibitor and Vascular Events and Premature Death in Patients with Type 2 Diabetes-The ADVANCE Trial', in DIABETES, AMER DIABETES ASSOC, FL, Orlando, presented at 78th Scientific Sessions of the American-Diabetes-Association, FL, Orlando, 22 June 2018 - 26 June 2018, http://dx.doi.org/10.2337/db18-1483-P

Mahaffey KW; Neal B; Perkovic V; de Zeeuw D; Fulcher G; Erondu N; Shaw W; Sun T; Desai M; Matthews DR, 2017, 'Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program', in CIRCULATION, LIPPINCOTT WILLIAMS & WILKINS, CA, Anaheim, pp. E454 - E455, presented at Scientific Sessions of the American-Heart-Association / Resuscitation Science Symposium, CA, Anaheim, 11 November 2017 - 15 November 2017, http://dx.doi.org/10.26190/unsworks/28470

Perkovic V; Rosenstock J; MacGuire DK, 2017, 'CARMELINA® trial baseline characteristics: a cardiovascular and renal microvascular outcome trial with linagliptin in patients with type 2 diabetes at high vascular risk', in DIABETOLOGIA, SPRINGER, PORTUGAL, Lisbon, pp. S357 - S357, presented at 53rd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), PORTUGAL, Lisbon, 11 September 2017 - 15 September 2017

Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Kahn SE; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; George JT; Broedl UC; Woerle H-J; Von Eynatten M; Mcguire DK, 2017, 'CARMELINA (R) Trial Baseline Characteristics: A Cardiovascular and Renal Microvascular Outcome Trial with Linagliptin in Patients with Type 2 Diabetes at High Vascular Risk', in DIABETES, AMER DIABETES ASSOC, CA, San Diego, pp. A344 - A344, presented at 77th Scientific Sessions of the American-Diabetes-Association, CA, San Diego, 09 June 2017 - 13 June 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000408064102388&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page